PRK1 (PKN) is a serine
number of protein kinases including protein-tyrosine kinases (e.g. Cdc42-Ack (18) ) and protein serine/threonine kinases (e.g. Ras-Raf (19 -21) and Rac/Cdc42-p65 PAK (22, 23) ). Recently, a number of targets for Rho have been reported (1, 24 -27) . These have been identified through conventional protein-protein interactions as well as through yeast two-hybrid screening. Among the targets identified as Rho-binding proteins is the lipid-activated protein serine/threonine kinase PRK1/PKN 1 (29 -31) . This kinase and two related sequences were originally identified in screens for protein kinase C gene products; however, it is clear that these proteins are in fact quite distinct from protein kinase C within their regulatory domains. The complete cDNA cloning of PRK1 and PRK2 has revealed conserved regulatory domain features in these predicted proteins absent from protein kinase C (31), although it should be noted that one domain is predicted to retain some structural resemblance to the protein kinase C C2 domain (32) . PRK1 has been shown to bind to and be stimulated by RhoA in vitro (1) ; it has been demonstrated also to be activated by various fatty acids and phosphoinositides (33, 34) . The precise molecular action of these effector molecules on PRK1 is poorly understood.
The potential importance of the Rho-PRK pathway in controlling cell functions has led us to define the site of interaction of these proteins. Interestingly, the results demonstrate that in fact RhoA can make two independent contacts with PRK1 that differ in their dependence upon RhoA conformation and lead to a high affinity interaction. The two target sites on PRK1 are homologous and define a class of binding sites for Rho.
EXPERIMENTAL PROCEDURES
DNA Constructs-The full-length PRK1 was inserted into the mammalian expression vector (Invitrogen). PRK1 cDNA was digested with BssHI and XhoI; the BssHI site was blunt-ended with mung bean nuclease, and the purified fragment was inserted into the EcoRV/XhoI sites of pcDNA3. The PRK2 HR1abc fragment (amino acids 1-380) was subcloned into the bacterial expression vector pGEX-2TK (Pharmacia Biotech Inc.) at the BamHI/EcoRI site. DNA fragments encoding various PRK1 HR1 motifs were amplified by PCR using Vent DNA polymerase (New England Biolabs) and the following oligonucleotide primers :  HR1a  PRK1 , 5Ј-GGGATCCCCATGGCCAGCGACGCCGTG-3Ј and 5Ј-CC-TCGAGTCAGGTGGCCGCCGGGTCGGG-3Ј; HR1b  PRK1 , 5Ј-GGGGAT-CCCCGCCACCAACCTGAGCCGC-3Ј and 5Ј-CCCTCGAGTCACGGGG-CTGCCTGGTTCTC-3Ј; HR1c  PRK1 , 5Ј-GGGGATCCCCGATGACACCC-AAGGGAGT-3Ј and 5Ј-CCCTCGAGTCAAGCGAGCTCTTCTCGCAG-3Ј; HR1abc   PRK1   , 5Ј-GGGATCCCCATGGCCAGCGACGCCGTG-3Ј and  5Ј-GGGGATCCCCGATGACACCCAAGGGAGT-3Ј; F46F6.2 HR1a, 5Ј-TGGGATCCCCGGCACTTATTGGGAGACA-3Ј and 5Ј-CCCTCGAGCT-AAAAAGCTCCACTGTTGT-3Ј . The products were digested with BamHI and XhoI and subcloned into the BamHI/XhoI site of pGEX-5X-1 (Pharmacia). All of the constructs were confirmed by sequencing.
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The small G-protein constructs, both wild type and chimeric, have been described previously (35) .
Purification and Nucleotide Loading of Recombinant Proteins-The full-length PRK1 in pcDNA3 was transfected into COS7 cells by electroporation, expressed for 36 h, and harvested directly into SDS-PAGE 2 sample buffer. The various cDNA constructs in pGEX vectors were expressed in the Escherichia coli Bl21 bacterial strain and purified by affinity chromatography on glutathione-Sepharose. The GST-GTPase fusion proteins were cleaved by thrombin treatment (3 units/liter of culture), whereas the purified kinase fragments were eluted as fusion proteins from the Sepharose with 10 mM reduced glutathione. The relative nucleotide loading capacities of the small GTPases used in all of the studies were determined by a guanine nucleotide filter binding assay (36) . Briefly, GTPases were incubated with [␣-
32 P]GTP in a low MgCl 2 buffer for 20 min at 30°C followed by the addition of excess MgCl 2 and filtering through prewetted nitrocellulose using a Millipore filtration device. Filters were washed, and bound nucleotide was determined by scintillation counting. The relationship between mol of nucleotide retained on the filters and mol of GTPase present was used to calculate the percentage of nucleotide loading capacity.
Overlay Assay-Proteins separated by SDS-PAGE were transferred to nitrocellulose, and the filters were incubated in renaturation solution: phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin (BSA), 0.5 mM MgCl 2 , 50 l of ZnCl 2 , 0.1% Triton X-100, and 5 mM dithiothreitol (25) for 15 h at 4°C, followed by blocking in 1% BSA, 0.1% Tween 20 for 1 h. The recombinant, wild-type RhoA, which had previously been determined to have approximately 10% nucleotide loading capacity, was radiolabeled by incubating 10 M protein with 20 Ci of [␣-32 P]GTP (3000 Ci/mmol) in PBS with 2 mM dithiothreitol, 5 mM EDTA, and 1 mg/ml BSA for 30 min at 30°C. Nucleotide exchange was stopped by adding 10 mM MgCl 2 and placing the reaction on ice. The filters were then incubated in PBS with 10 mM MgCl 2 and 2 mg/ml of the radiolabeled RhoA for 30 min at 4°C, followed by two washes in PBS containing 10 mM MgCl 2 at 4°C. The bound [␣-
32 P]GTP-loaded RhoA was then visualized by autoradiography.
For the chimeric protein overlays, equimolar amounts of the HR1 PRK1 constructs were subjected to SDS-PAGE and transferred to nitrocellulose followed by renaturation and blocking (as above). The nucleotide loading capacity of the Rho/Rac chimeras, as well as the positive and negative controls were determined prior to the overlay, which was carried out exactly as above.
BIAcore-BIAcore methodologies employed were as previously published (37) . All experiments were performed at 25°C and at a constant flow of 5 l/min in running buffer: phosphate-buffered saline, 10 mM MgCl 2 . For immobilization of proteins, a carboxymethylated dextran layer on a CM5 sensor chip (Pharmacia) was activated by a 40-l injection of a 1:1 mixture of 11.5 mg/ml N-hydroxysuccinimide and 75 mg/ml N-ethyl-NЈ-(3-dimethylaminopropyl)-carbodiimide. Proteins were diluted in coupling buffer (10 mM acetate buffer, pH 4.5) and injected over the activated surface. Excess, uncoupled sites were blocked by an injection of 1 M ethanolamine. Rho proteins were passed through small desalting columns (NICK columns, Pharmacia) to exchange them into running buffer (as above) and were then injected over the immobilized proteins at a concentration of between 10 and 20 g/ml. The response was recorded in arbitrary resonance units (RU), and the resulting RU versus time plots were analyzed with the evaluation software supplied with the instrument.
Solution Binding Assay-Equimolar amounts of the PRK1 GST fusion proteins; HR1abc PRK1 , HR1a PRK1 , HR1b PRK1 , HR1c PRK1 , and GST control were bound to glutathione-Sepharose, which was packed into Clontech minicolumns (50-l bed volume). Any nonspecific sites on either the column or the Sepharose were then blocked by washing the columns with Buffer A: PBS containing 10 mM MgCl 2 , 1 mg/ml BSA, and 0.1 mM GTP or GDP.
The recombinant wild type RhoA (10 or 20 g, as indicated) was loaded with either GTP or GDP by incubation with an excess of the nucleotide in the presence of 2 mM dithiothreitol, 5 mM EDTA, and 1 mg/ml BSA at 30°C for 30 min. The reaction was stopped by the addition of 10 mM MgCl 2 . The nucleotide-loaded RhoA was applied to the Sepharose columns, and the flow through the columns was blocked for an incubation period of 1 h. The columns were then washed with Buffer A using either 0.4 ml (8 ϫ Sepharose bed volume) for the experiment shown in Fig. 5A or 0, 0.25, 1.00, and 4.00 ml for the experiment in Fig. 5B . Proteins were then eluted using 20 mM glutathione. Both the application of the RhoA and the subsequent washes were carried out at 4°C, whereas the glutathione-dependent elution was performed at room temperature.
Samples of the eluate were subjected to 15% SDS-PAGE, transferred (amino acids 1-380 was a His-ragged construct). The bacterial proteins were fractionated by SDS-PAGE and transferred to nitrocellulose for overlay (see "Experimental Procedures").
to nitrocellulose, and blotted for RhoA. The same procedure was employed for the Caenorhabditis elegans GST-HR1a immobilized on glutathione-Sepharose.
RESULTS
PRK1 has been identified as a target for RhoA through yeast two-hybrid analysis and direct protein-protein interaction (see Introduction). To delineate the RhoA binding site on PRK1, attention was focused on the noncatalytic regulatory domain of the protein. We had previously identified two domains in PRK1, HR1 and HR2, based upon conservation with PRK2 (see Fig. 1 ). The full-length PRK1 as well as these two regulatory domains were expressed, and binding of [ 32 P]GTP-bound RhoA was determined by overlay. Full-length PRK1 itself bound RhoA in this assay as shown in Fig. 2A . No equivalent binding activity was detected in COS cell extracts from vector-transfected cells. An E. coli-expressed GST fusion of HR1 PRK1 also bound RhoA, while GST itself did not (Fig. 2B) . No binding was observed for HR2 PRK1 (data not shown). Consistent with the binding activity of the HR1 PRK1 domain, the homologous domain from PRK2 was found also to bind RhoA (Fig. 2B ). The specificity with respect to G-protein was tested by comparison with [ 32 P]GTP-bound Rac1 and Cdc42, neither of which were found to bind HR1 PRK1 effectively (data not shown; see below). Since we had defined the HR1 domain as three consecutive repeats of a ϳ100-amino acid motif, these were expressed individually as subdomains, as defined under "Experimental Procedures." The a, b, and c repeat motifs (denoted HR1a PRK1 , etc) were expressed as GST fusion proteins and purified for analysis by overlay. Interestingly, both the HR1a PRK1 and HR1b
PRK1
GST fusion proteins bound RhoA; no binding was observed for HR1c PRK1 nor for the GST control (Fig. 3A) . The greater sequence similarity between HR1a PRK1 and HR1b PRK1 compared with HR1c PRK1 (Fig. 1) is consistent with this pattern of behavior.
The RhoA binding property ascribed to both the HR1a
and HR1b PRK1 repeats suggests that this defines a subdomain that has predictive value for RhoA targets. To test this notion, we identified a C. elegans open reading frame encoding a protein kinase that has an amino-terminal HR1 domain. The HR1a sequence from this gene was cloned, expressed as a GST fusion protein, and purified. This repeat was also found to bind RhoA in an overlay assay (Fig. 3B) . The data indicate that the HR1a repeat provides a useful predictive sequence for the identification of Rho targets.
To further characterize the multiple HR1 PRK1 -RhoA binding sites and define the nucleotide dependence of this interaction, binding was monitored using a BIAcore; this permitted a real time evaluation of RhoA-HR1 PRK1 interactions. For these studies, RhoA was loaded with nucleotide immediately prior to use. As illustrated in Fig. 4 , the complete HR1 PRK1 (HR1abc) domain bound RhoA in a GTP-dependent manner. Consistent with the overlay assay, both HR1a PRK1 and HR1b PRK1 but not HR1c PRK1 also bound RhoA. However, in contrast to HR1a PRK1 , where binding was completely specific to GTP-RhoA, for HR1b PRK1 a degree of binding over background was observed for GDP-RhoA. There was no specific binding of RhoA (GTP-or GDP-loaded) to the HR1c PRK1 domain when compared with the GST control.
While it is possible to obtain kinetic parameters (such as association and dissociation rates) from BIAcore data, a simple correlation between the present data and defined kinetic models for a one-or two-site interaction was not seen. Furthermore, the immobilized ligands were found to be unstable after a few rounds of interaction and regeneration, precluding the determination of equilibrium binding over a range of RhoA concentrations. It should be noted also that the complexity of HR1-RhoA interactions does not reflect mass transport-related distortions as judged by plots of ln(abs dR/dt). Thus, the data indicate that the binding of HR1 and RhoA is not simple in this context. This situation might have arisen from the dimerization state of the immobilized fusion proteins due to their GST tags; however, the observed homooligomerization of the individual HR1 repeats after cleavage from their expression tags 3 precluded the use of cleaved proteins as a means of obtaining a clearer result. Consequently, the comparisons made here are semiquantitative; proteins that give the highest response in RU are presumed to have the highest affinity for the immobilized ligand, i.e. PRK1 (see Fig. 6 ) and was found to display complete GTP dependence for maintenance of RhoA binding (Fig. 5B) .
The dissociation of these RhoA complexes was assessed by a sequential washing protocol. The stable association of HR1abc PRK1 to RhoA occurred with a distinct, but not exclusive, preference for the GTP-bound state (Fig. 6) . For HR1a PRK1 , sequential washing revealed no stable binding of GDP-RhoA, while GTP-RhoA was retained. HR1b PRK1 was found to bind stably to GDP-RhoA in addition to GTP-RhoA, with equivalent dissociation after washing with 20 bed volumes (Fig.  6) . The different properties of the HR1a PRK1 and HR1b PRK1 in the retention and dissociation of GTP-RhoA and GDP-RhoA are consistent with the BIAcore data. These results demonstrate that although homologous, these HR1 repeats make different contacts with RhoA. Furthermore, it appears that the specific properties of the HR1a PRK1 repeat are retained for HR1a F46F6.2 . It is implicit in the conclusions above that HR1a PRK1 and HR1b PRK1 bind distinct sites on RhoA. To establish whether these are overlapping or whether in fact two simultaneous contacts might be made between RhoA and PRK1, "fragmentation" of RhoA was employed through the use of the Rac-Rho chimera. It has been established previously that PRK1 does not bind Rac (1); however, here a very low level of Rac association with HR1a is reproducibly seen (see below). This degree of binding is mirrored by the Rac143Rho chimera. The chimera were loaded with equal efficiency (see "Experimental Procedures"), demonstrating the integrity of each of the constructs employed. These chimera were assessed for interactions with HR1a PRK1 , HR1b PRK1 , and HR1c PRK1 using an overlay assay, to reduce any influence of the oligomeric state of the HR1 proteins on binding. As shown in Fig. 7A, it To further assess the binding of HR1b to the amino-terminal region of RhoA, the "activating" V14RhoA mutant was employed. As shown in Fig. 7B , the mutant failed to bind HR1b while retaining binding to HR1a. Since HR1b binds GTP-RhoA, the inability of this domain to bind V14RhoA implies a contact within the amino-terminal region close to residue 14 and not a consequence of the activating conformational changes induced by this mutation.
DISCUSSION
Previous studies have identified PRK1 (PKN) as a target for RhoA (1, 27) and indeed demonstrated a modest activation of this protein kinase by GTP-RhoA (1). The work described here defines a two-site interaction between RhoA and PRK1. Interestingly, the two regions of contact within the PRK1 protein are in the regulatory domain and are defined by the first two HR1 repeats, a and b. Of the three repeats present, these are the two with the most similar amino acid sequences (see Fig. 1 ). Despite the similarity of the HR1a PRK1 and HR1b PRK1 repeats, these proteins have differing specificities for RhoA; HR1a PRK1 binds to only the GTP-bound form of RhoA, and HR1b PRK1 binds to both GTP-and GDP-bound forms. This implies that within the context of PRK1 itself, HR1a
PRK1 makes contact with a conformation determined by GTP binding, while HR1b PRK1 does not. Indeed, the properties of the intact HR1abc PRK1 domain are consistent with this, given its preferential but nonexclusive binding to the GTP-bound form of RhoA. It can be concluded that tight binding of GTP-RhoA for intact PRK1 is effected through the combined contacts of the HR1a PRK1 and HR1b PRK1 motifs. These interactions are summarized in Fig. 8 (see below) . That HR1abc PRK1 does indeed bind more tightly than either HR1a PRK1 or HR1b PRK1 alone is evidenced by the slower dissociation of RhoA seen for the immobilized HR1 repeats. Precise dissociation rates based upon the BIAcore analysis could not be derived, since the binding data did not fit rigorously the binding models tested.
The elucidation of the binding activities of these HR1 repeat motifs indicates that there is indeed a reason for defining these as functional units. Previously, these repeats had been defined only on the basis of conservation between the PRK1 and PRK2 gene products (31) . The demonstration that the HR1 domain of PRK2 also confers GTP-RhoA binding is entirely consistent with this analysis. Furthermore, the predictive nature of the HR1 repeat motif has been established by demonstration that such a sequence from a C. elegans open reading frame will also bind GTP-RhoA. Similar HR1 repeat sequences are found in numerous other proteins including rhotekin, which interestingly has only the HR1a motif and has been shown to bind Rho in a GTP-dependent manner (26) . During revision of this submission, it was reported that PRK2 binds to RhoA in a nucleotide-independent manner (38) . This is compatible with the finding here that PRK1 also makes a nucleotide-independent contact. However, for the intact RhoA binding domain of PRK1, a relative GTP dependence is observed, demonstrating a significant contribution from the HR1a-RhoA contact; it would appear that in PRK2, the predicted nucleotide-independent contact with the HR1b PRK2 domain is dominant. It is also notable that PRK2 will bind Rac, albeit less effectively than RhoA (38) ; the very weak binding of HR1a PRK1 to Rac observed here indicates a similar property for PRK1.
It has been reported recently that RhoA binds PRK1 through an amino-terminal region that encompasses the HR1a repeat (27) . This is consistent with the results here, albeit only a partial solution to the RhoA-PRK1 interaction as defined here. Additionally, Ono and colleagues (39) have provided evidence for a pseudosubstrate motif in the basic region of the HR1a repeat, and it is possible that sequestration of this region alongside the basic region also conserved in the HR1b repeat contributes to the RhoA-dependent activation of PRK1 (see Fig.  8 ).
A notable feature of the PRK1-RhoA interaction is that these homologous repeats within the HR1 domain bind to distinct target sites on RhoA. The RhoA/Rac chimera analysis is consistent with HR1b PRK1 interaction with the RhoA amino terminus (residues 1-73) and HR1a PRK1 interaction with RhoA between residues 73 and 143 (see Fig. 7 ). The RhoA/Rac chimera (i.e. RhoA1-73Rac) that would be predicted to bind HR1b PRK1 but not HR1a PRK1 degrades during purification; hence, it has not proved possible to confirm this prediction. The finding that the V14 point mutant in RhoA fails to bind HR1b while still binding HR1a corroborates the conclusion from the chimera analysis that the HR1b binds to the amino-terminal region of RhoA. Furthermore, the more avid binding of RhoA to HR1abc compared with HR1a or HR1b indicates that both RhoA sites are contacted upon interaction with the intact HR1 domain. It is noteworthy that the binding of HR1abc to GDPRhoA resembles that of HR1b alone; i.e. a single lower affinity contact is made for GDP-RhoA. While it is concluded that the binding of HR1abc to GTP-RhoA involves both HR1a and HR1b contact, independent proof of this from competition analysis has not been possible, since recombinant HR1a and HR1b domains interact directly in vitro. 3 Furthermore, overlapping oligopeptides based upon RhoA covering the entire predicted FIG. 6 . Sequential washing was employed to define the dissociation behavior of the HR1 repeats with respect to their nucleotide dependences for RhoA (10 g) binding. Following various volumes of washing as indicated, the bound RhoA complex was eluted with glutathione and detected by Western analysis. Purified GST itself was employed as a control. Autoradiographs were analyzed for signal intensity to give arbitrary units for the amount of RhoA bound to Sepharose. f, RhoGTP; ᭜, RhoGDP.
binding regions for HR1a and HR1b (residues 1-100) are neither able to interact directly nor able to compete for HR1a/ HR1b binding to RhoA, indicating that the sites of interaction on RhoA are sensitive to conformational constraints.
The site of interaction on RhoA for HR1a PRK1 (amino acids 73-143) overlaps the Switch II region of RhoA, suggesting that this may be involved in the GTP-dependent contact. By contrast, while HR1b PRK1 is predicted to bind to the amino-terminal region of RhoA (amino acids 1-73), the nucleotide dependence of this interaction indicates that the Switch I region is unlikely to be involved. One can speculate that duplication of this HR1 motif has permitted the evolution of a high affinity (two contacts) RhoA binding domain. It is of interest that the interaction of Ras with c-Raf is also thought to operate through two sites (40 -42) . However, in this case the points of contact in the effector (i.e. Raf) are not themselves homologous. A clear precedent for asymmetric interactions of homologous proteins is afforded by the growth hormone receptor; here the two identical receptors contact distinct sites on growth hormone causing dimerization (43) . In PRK1, there is no evidence for dimerization, and in fact the HR1abc PRK1 domain is likely to form a discrete folded domain, since HR1b
PRK1 alone behaves as a dimer on gel filtration. 4 Whether this behavior is consequent upon the predicted leucine zipper that is part of each HR1 repeat motif awaits further analysis. The results described here establish the nature of the RhoA binding site on PRK1 and PRK2. Further, the dissection of this site on PRK1 demonstrates that the strong interaction between regulator (RhoA) and effector (PRK1) is driven by a bipartite interaction involving sequential repeats on PRK1 and distinct regions on RhoA. The actual molecular organization of this interaction will require direct structural analysis. 
